In Dog, Inc., investigative journalist John Woestendiek delves into the stranger-than-fiction world of commercial canine cloning. From the groundbreaking cloning of Booger, a pit bull whose owner paid a substantial fee to RNL Bio, to the rise of a new biotech industry, Woestendiek reveals how emotional bonds with pets are reshaping science and commerce.

Blending in-depth reporting with engaging anecdotes, the book examines key ethical dilemmas, scientific breakthroughs and the growing market for pet replication. Readers will discover what drives owners to recreate beloved companions and how companies navigate uncharted moral and legal territory.

Highlights include:

• The first successful commercial dog clone and its implications
• The balance between scientific ambition and emotional need
• Emerging trends and future prospects in animal biotechnology

We ship at a flat rate of $9.99 per order. Orders $45 and up ship free of charge.